To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Key Takeaways IRWD stock jumped 26.7% on Jan. 2 after the company issued upbeat revenue guidance for 2026.Ironwood expects $450-$475M in 2026 revenues and more than $300M in adjusted EBITDA.IRWD to start a phase III study on apraglutide in 1H26 after aligning with the FDA on study design.Shares of Ironwood Pharmaceuticals (IRWD) were up 26.7% on Jan. 2 after the company announced upbeat revenue guidance for 2026. The company maintained its revenue guidance for full-year 2025, which it had provided in Novemb ...

Group 1 - The article does not provide any specific content related to a company or industry [1]

Core Insights - The investor reaction to Phreesia's third-quarter performance was overly negative despite the company showing significant improvements in revenue and profitability [1][8] Financial Performance - Phreesia reported a 13% year-over-year increase in revenue, exceeding $120 million, driven by a 7% growth in the average number of healthcare services clients to 4,520 [2][4] - The company achieved a net profit of nearly $4.3 million ($0.07 per share), a turnaround from a loss of $14.4 million in the same quarter last year, with both revenue and profit figures surpassing analyst expectations [4][5] Revenue Streams - All three revenue streams—subscription and related services, network solutions, and payment processing—grew at low double-digit rates of 12%, 14%, and 11% respectively during the quarter [5] Guidance and Market Reaction - Phreesia tightened its full-year 2026 revenue guidance to $479 million to $481 million, slightly below analyst expectations of nearly $486 million [6] - The company's forecast for non-GAAP EBITDA was raised to $99 million to $101 million, up from a previous range of $89 million to $92 million [7] - Despite the stock's significant drop of over 23% following the earnings release, the negative sentiment appears exaggerated, primarily due to the revenue guidance miss [1][8]

Group 1 - The article does not provide any specific content related to a company or industry [1]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Core Points - The article emphasizes the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1] Summary by Categories Technical Requirements - Users are advised to enable Javascript and cookies in their browsers to ensure proper functionality [1] - The presence of ad-blockers can lead to blocked access, necessitating their temporary disablement [1]

Core Points - The article emphasizes the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1] Summary by Categories Technical Requirements - Users are advised to enable Javascript and cookies in their browsers to ensure proper functionality [1] - The presence of ad-blockers can lead to blocked access, necessitating their temporary disablement [1]

Group 1 - The article does not provide any specific content or key points related to a company or industry [1]

Group 1 - The article discusses the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1]